10/02/2026
Our friends at Ma*****na Moment reported earlier this week that the DEA administrative law judge has paused the ma*****na rescheduling proceeding while the parties address a new Government Accountability Office report criticizing gaps in the federal drug scheduling process. For anyone concerned that this somehow reverses what happened earlier this year with medical ma*****na, it does not.
What has been delayed is the broader proceeding that would move adult use ma*****na into Schedule III. That is still a big deal for the industry. According to BDSA, adult use cannabis sales were approximately $23.9 billion in 2025 compared with $7.6 billion of medical sales. That means roughly three quarters of the regulated cannabis market is adult use. For businesses operating only in adult use markets, we are going to have to wait a little longer. For businesses operating in states with both medical and adult use programs, I think the situation is much more interesting.
- Justin Botillier.